Xin Lang Cai Jing·2025-09-09 02:10Company Overview - Spring Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with a focus on joint prosthetics and spinal implants [2] - The company was established on February 12, 1998, and went public on December 30, 2021 [2] - Its main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems [2] Financial Performance - For the first half of 2025, Spring Medical reported a revenue of 488 million yuan, representing a year-on-year growth of 28.27% [3] - The net profit attributable to shareholders for the same period was 114 million yuan, showing a year-on-year increase of 44.85% [3] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [4] Stock Performance - As of September 9, Spring Medical's stock price has increased by 91.98% year-to-date, with a 9.09% rise over the last five trading days [2] - The stock experienced a 2.39% decline over the past 20 days but has risen by 45.10% over the last 60 days [2] - The company's market capitalization is approximately 9.39 billion yuan, with a trading volume of 18.62 million yuan on September 9 [1] Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 17.57% to 5,920, while the average number of tradable shares per person increased by 341.41% to 48,836 shares [3] - Among the top ten circulating shareholders, Ping An Low Carbon Economy Mixed A (009878) is the fourth largest, increasing its holdings by 2.77 million shares [4] - New shareholder South Pharmaceutical Health Flexible Allocation Mixed A (000452) entered the top ten, holding 1.603 million shares [4]